APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Armodafinil Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Armodafinil Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173967260327 December 2025180 pages

Choose your research edition.

Industry ResearchArmodafinil Tablets Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Armodafinil Tablets Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Armodafinil Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Armodafinil Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Armodafinil Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Armodafinil Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Armodafinil Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Armodafinil Tablets include Sandoz, Mylan, Aurobindo Pharma, Natco Pharma, Lupin, Cephalon, Apotex and Actavis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Armodafinil Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Armodafinil Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Armodafinil Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Armodafinil Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Armodafinil Tablets Segment by Company

Sandoz

Mylan

Aurobindo Pharma

Natco Pharma

Lupin

Cephalon

Apotex

Actavis

Armodafinil Tablets Segment by Type

150mg per Tablet

200mg per Tablet

250mg per Tablet

50mg per Tablet

Armodafinil Tablets Segment by Application

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Narcolepsy

Other

Armodafinil Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Armodafinil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Armodafinil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Armodafinil Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Armodafinil Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Armodafinil Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Armodafinil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Armodafinil Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Armodafinil Tablets Industry Trends Table 2. Armodafinil Tablets Industry Drivers Table 3. Armodafinil Tablets Industry Opportunities and Challenges Table 4. Armodafinil Tablets Industry Restraints Table 5. Global Armodafinil Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Armodafinil Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Armodafinil Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Armodafinil Tablets Sales Market Share by Manufacturers Table 9. Global Armodafinil Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Armodafinil Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Armodafinil Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Armodafinil Tablets Manufacturers, Product Type & Application Table 13. Global Armodafinil Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Armodafinil Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 150mg per Tablet Table 17. Major Manufacturers of 200mg per Tablet Table 18. Major Manufacturers of 250mg per Tablet Table 19. Major Manufacturers of 50mg per Tablet Table 20. Global Armodafinil Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Armodafinil Tablets Sales by Type (2021-2026) & (K Units) Table 22. Global Armodafinil Tablets Sales by Type (2027-2032) & (K Units) Table 23. Global Armodafinil Tablets Sales Market Share by Type (2021-2026) Table 24. Global Armodafinil Tablets Sales Market Share by Type (2027-2032) Table 25. Global Armodafinil Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Armodafinil Tablets Revenue by Type (2021-2026) & (K Units) Table 27. Global Armodafinil Tablets Revenue by Type (2027-2032) & (K Units) Table 28. Global Armodafinil Tablets Revenue Market Share by Type (2021-2026) Table 29. Global Armodafinil Tablets Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Obstructive Sleep Apnea Table 31. Major Manufacturers of Shift Work Sleep Disorder Table 32. Major Manufacturers of Narcolepsy Table 33. Major Manufacturers of Other Table 34. Global Armodafinil Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Armodafinil Tablets Sales by Application (2021-2026) & (K Units) Table 36. Global Armodafinil Tablets Sales by Application (2027-2032) & (K Units) Table 37. Global Armodafinil Tablets Sales Market Share by Application (2021-2026) Table 38. Global Armodafinil Tablets Sales Market Share by Application (2027-2032) Table 39. Global Armodafinil Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Armodafinil Tablets Revenue by Application (2021-2026) & (K Units) Table 41. Global Armodafinil Tablets Revenue by Application (2027-2032) & (K Units) Table 42. Global Armodafinil Tablets Revenue Market Share by Application (2021-2026) Table 43. Global Armodafinil Tablets Revenue Market Share by Application (2027-2032) Table 44. Global Armodafinil Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Armodafinil Tablets Sales by Region (2021-2026) & (K Units) Table 46. Global Armodafinil Tablets Sales Market Share by Region (2021-2026) Table 47. Global Armodafinil Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Armodafinil Tablets Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 51. North America Armodafinil Tablets Sales by Country (2027-2032) & (K Units) Table 52. Europe Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 54. Europe Armodafinil Tablets Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Armodafinil Tablets Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Armodafinil Tablets Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Armodafinil Tablets Sales by Country (2027-2032) & (K Units) Table 61. Global Armodafinil Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Armodafinil Tablets Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Armodafinil Tablets Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Armodafinil Tablets Revenue Market Share by Region (2021-2026) Table 65. Global Armodafinil Tablets Revenue Market Share by Region (2027-2032) Table 66. Sandoz Company Information Table 67. Sandoz Business Overview Table 68. Sandoz Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sandoz Armodafinil Tablets Product Portfolio Table 70. Sandoz Recent Development Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Mylan Armodafinil Tablets Product Portfolio Table 75. Mylan Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Armodafinil Tablets Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. Natco Pharma Company Information Table 82. Natco Pharma Business Overview Table 83. Natco Pharma Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Natco Pharma Armodafinil Tablets Product Portfolio Table 85. Natco Pharma Recent Development Table 86. Lupin Company Information Table 87. Lupin Business Overview Table 88. Lupin Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Lupin Armodafinil Tablets Product Portfolio Table 90. Lupin Recent Development Table 91. Cephalon Company Information Table 92. Cephalon Business Overview Table 93. Cephalon Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Cephalon Armodafinil Tablets Product Portfolio Table 95. Cephalon Recent Development Table 96. Apotex Company Information Table 97. Apotex Business Overview Table 98. Apotex Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Apotex Armodafinil Tablets Product Portfolio Table 100. Apotex Recent Development Table 101. Actavis Company Information Table 102. Actavis Business Overview Table 103. Actavis Armodafinil Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Actavis Armodafinil Tablets Product Portfolio Table 105. Actavis Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Armodafinil Tablets Distributors List Table 109. Armodafinil Tablets Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Armodafinil Tablets Product Image Figure 2. Global Armodafinil Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Armodafinil Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Armodafinil Tablets Sales (2021-2032) & (K Units) Figure 5. Global Armodafinil Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Armodafinil Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 150mg per Tablet Image Figure 9. 200mg per Tablet Image Figure 10. 250mg per Tablet Image Figure 11. 50mg per Tablet Image Figure 12. Global Armodafinil Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Armodafinil Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Armodafinil Tablets Sales Market Share by Type (2021-2032) Figure 15. Global Armodafinil Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Armodafinil Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Armodafinil Tablets Revenue Market Share by Type (2021-2032) Figure 18. Obstructive Sleep Apnea Image Figure 19. Shift Work Sleep Disorder Image Figure 20. Narcolepsy Image Figure 21. Other Image Figure 22. Global Armodafinil Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Armodafinil Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Armodafinil Tablets Sales Market Share by Application (2021-2032) Figure 25. Global Armodafinil Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Armodafinil Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Armodafinil Tablets Revenue Market Share by Application (2021-2032) Figure 28. North America Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Armodafinil Tablets Sales Market Share by Country (2021-2032) Figure 30. U.S. Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Armodafinil Tablets Sales Market Share by Country (2021-2032) Figure 35. Germany Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Armodafinil Tablets Sales Market Share by Country (2021-2032) Figure 42. China Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Armodafinil Tablets Sales Market Share by Country (2021-2032) Figure 50. Brazil Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Armodafinil Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Armodafinil Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Armodafinil Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Armodafinil Tablets Revenue (2021-2032) & (US$ Million) Figure 61. North America Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Armodafinil Tablets Revenue (2021-2032) & (US$ Million) Figure 63. Europe Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Armodafinil Tablets Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Armodafinil Tablets Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Armodafinil Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Armodafinil Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg per Tablet
  • 200mg per Tablet
  • 250mg per Tablet
  • 50mg per Tablet
Applications
  • Obstructive Sleep Apnea
  • Shift Work Sleep Disorder
  • Narcolepsy
  • Other
Companies covered
  • Sandoz
  • Mylan
  • Aurobindo Pharma
  • Natco Pharma
  • Lupin
  • Cephalon
  • Apotex
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Armodafinil Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Armodafinil Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Armodafinil Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Armodafinil Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Armodafinil Tablets Market Dynamics
  1. 2.1 Armodafinil Tablets Industry Trends
  2. 2.2 Armodafinil Tablets Industry Drivers
  3. 2.3 Armodafinil Tablets Industry Opportunities and Challenges
  4. 2.4 Armodafinil Tablets Industry Restraints
3 Armodafinil Tablets Market by Manufacturers
  1. 3.1 Global Armodafinil Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Armodafinil Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Armodafinil Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Armodafinil Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Armodafinil Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Armodafinil Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Armodafinil Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Armodafinil Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Armodafinil Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Armodafinil Tablets Tier 1, Tier 2, and Tier 3
4 Armodafinil Tablets Market by Type
  1. 4.1 Armodafinil Tablets Type Introduction
  2. 4.1.1 150mg per Tablet
  3. 4.1.2 200mg per Tablet
  4. 4.1.3 250mg per Tablet
  5. 4.1.4 50mg per Tablet
  6. 4.2 Global Armodafinil Tablets Sales by Type
  7. 4.2.1 Global Armodafinil Tablets Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Armodafinil Tablets Sales by Type (2021-2032)
  9. 4.2.3 Global Armodafinil Tablets Sales Market Share by Type (2021-2032)
  10. 4.3 Global Armodafinil Tablets Revenue by Type
  11. 4.3.1 Global Armodafinil Tablets Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Armodafinil Tablets Revenue by Type (2021-2032)
  13. 4.3.3 Global Armodafinil Tablets Revenue Market Share by Type (2021-2032)
5 Armodafinil Tablets Market by Application
  1. 5.1 Armodafinil Tablets Application Introduction
  2. 5.1.1 Obstructive Sleep Apnea
  3. 5.1.2 Shift Work Sleep Disorder
  4. 5.1.3 Narcolepsy
  5. 5.1.4 Other
  6. 5.2 Global Armodafinil Tablets Sales by Application
  7. 5.2.1 Global Armodafinil Tablets Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Armodafinil Tablets Sales by Application (2021-2032)
  9. 5.2.3 Global Armodafinil Tablets Sales Market Share by Application (2021-2032)
  10. 5.3 Global Armodafinil Tablets Revenue by Application
  11. 5.3.1 Global Armodafinil Tablets Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Armodafinil Tablets Revenue by Application (2021-2032)
  13. 5.3.3 Global Armodafinil Tablets Revenue Market Share by Application (2021-2032)
6 Global Armodafinil Tablets Sales by Region
  1. 6.1 Global Armodafinil Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Armodafinil Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Armodafinil Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Armodafinil Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Armodafinil Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Armodafinil Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Armodafinil Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Armodafinil Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Armodafinil Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Armodafinil Tablets Revenue by Region
  1. 7.1 Global Armodafinil Tablets Revenue by Region
  2. 7.1.1 Global Armodafinil Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Armodafinil Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Armodafinil Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Armodafinil Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Armodafinil Tablets Revenue (2021-2032)
  8. 7.2.2 North America Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Armodafinil Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Armodafinil Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Armodafinil Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Armodafinil Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz
  2. 8.1.1 Sandoz Company Information
  3. 8.1.2 Sandoz Business Overview
  4. 8.1.3 Sandoz Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz Armodafinil Tablets Product Portfolio
  6. 8.1.5 Sandoz Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Armodafinil Tablets Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Aurobindo Pharma
  14. 8.3.1 Aurobindo Pharma Company Information
  15. 8.3.2 Aurobindo Pharma Business Overview
  16. 8.3.3 Aurobindo Pharma Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aurobindo Pharma Armodafinil Tablets Product Portfolio
  18. 8.3.5 Aurobindo Pharma Recent Developments
  19. 8.4 Natco Pharma
  20. 8.4.1 Natco Pharma Company Information
  21. 8.4.2 Natco Pharma Business Overview
  22. 8.4.3 Natco Pharma Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Natco Pharma Armodafinil Tablets Product Portfolio
  24. 8.4.5 Natco Pharma Recent Developments
  25. 8.5 Lupin
  26. 8.5.1 Lupin Company Information
  27. 8.5.2 Lupin Business Overview
  28. 8.5.3 Lupin Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lupin Armodafinil Tablets Product Portfolio
  30. 8.5.5 Lupin Recent Developments
  31. 8.6 Cephalon
  32. 8.6.1 Cephalon Company Information
  33. 8.6.2 Cephalon Business Overview
  34. 8.6.3 Cephalon Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cephalon Armodafinil Tablets Product Portfolio
  36. 8.6.5 Cephalon Recent Developments
  37. 8.7 Apotex
  38. 8.7.1 Apotex Company Information
  39. 8.7.2 Apotex Business Overview
  40. 8.7.3 Apotex Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Apotex Armodafinil Tablets Product Portfolio
  42. 8.7.5 Apotex Recent Developments
  43. 8.8 Actavis
  44. 8.8.1 Actavis Company Information
  45. 8.8.2 Actavis Business Overview
  46. 8.8.3 Actavis Armodafinil Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Actavis Armodafinil Tablets Product Portfolio
  48. 8.8.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Armodafinil Tablets Value Chain Analysis
  2. 9.1.1 Armodafinil Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Armodafinil Tablets Production Mode & Process
  6. 9.2 Armodafinil Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Armodafinil Tablets Distributors
  9. 9.2.3 Armodafinil Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst